Clinical trial for Low Back Pain
Official title ADHERE Trial: Strategies to Improve Mobile App Adherence
ClinicalTrials.gov ID: NCT07205991
What this study is testing
- What it's testing
- This study aims to look at the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Experiencing non-specific chronic low back pain (LBP), defined as pain between the 12th rib and the buttock crease.
- LBP with or without leg pain (in case of leg pain, LBP is worse than leg pain).
- Currently consulting with a general practitioner for their non-specific chronic LBP across Australia.
- Mean pain intensity score on the Numeric Rating Scale ≥ 3/10 in the past week.
- A score of at least moderate on question 8 of the physical functioning component of the SF-36 questionnaire.
You likely can't join if
- Known or suspected specific spinal (e.g., radiculopathy, fracture) or specific non-spinal non- (e.g., tumour, infection) pathology.
- Less than six months post-spinal surgery.
- Scheduled for major surgery during the program or the follow-up period.
- Known or suspected serious psychiatric condition not being treated by a health professional that would impact adherence to the trial activities.
- Known or suspected sight or hearing problems that would limit access to the intervention components (reading and listening using headphones).
See the full eligibility criteria
- Experiencing non-specific chronic low back pain (LBP), defined as pain between the 12th rib and the buttock crease.
- LBP with or without leg pain (in case of leg pain, LBP is worse than leg pain).
- Currently consulting with a general practitioner for their non-specific chronic LBP across Australia.
- Mean pain intensity score on the Numeric Rating Scale ≥ 3/10 in the past week.
- A score of at least moderate on question 8 of the physical functioning component of the SF-36 questionnaire.
- Access to a mobile device with minimal requirements to download the study app (300MB).
- An internet connection to access the mobile app functionalities.
- Able to understand English via reading and audio materials.
- assigned by chance to experimental group at NOTUS Trial.
- Known or suspected specific spinal (e.g., radiculopathy, fracture) or specific non-spinal non- (e.g., tumour, infection) pathology.
- Less than six months post-spinal surgery.
- Scheduled for major surgery during the program or the follow-up period.
- Known or suspected serious psychiatric condition not being treated by a health professional that would impact adherence to the trial activities.
- Known or suspected sight or hearing problems that would limit access to the intervention components (reading and listening using headphones).
The study team makes the final eligibility decision.
Where it is enrolling
- Sydney, New South Wales, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sydney, New South Wales, Australia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.